Agenus Inc. (AGEN)
NASDAQ: AGEN
· Real-Time Price · USD
4.78
-0.36 (-7.00%)
At close: Jun 17, 2025, 3:59 PM
4.92
3.04%
After-hours: Jun 17, 2025, 05:10 PM EDT
-7.00% (1D)
Bid | 4.68 |
Market Cap | 130.92M |
Revenue (ttm) | 99.52M |
Net Income (ttm) | -190.65M |
EPS (ttm) | 29.61 |
PE Ratio (ttm) | 0.16 |
Forward PE | 4.69 |
Analyst | Hold |
Ask | 4.93 |
Volume | 601,614 |
Avg. Volume (20D) | 996,453 |
Open | 5.10 |
Previous Close | 5.14 |
Day's Range | 4.75 - 5.17 |
52-Week Range | 1.38 - 18.74 |
Beta | 1.43 |
About AGEN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AGEN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+12.6%
Agenus shares are trading higher after HC Wainwrig...
Unlock content with
Pro Subscription
2 weeks ago
+21.07%
Agenus shares are trading higher after the company announced it signed a partnership agreement with Zydus Lifesciences to expand patient access to Botensilimab and Balstilimab.